SOVREMENNAYA PEDIATRIYA.2016.1(73):93-99; doi10.15574/SP.2016.73.93 

New possibilities of treatment and prevention of acute respiratory infections in children 

Abaturov O. Ye., Agafonova E. A., Babich V. L., Dityatkovskyi V. A.

SI «Dnepropetrovsk Medical Academy, Ministry of Health of Ukraine» 

Objective: To evaluate the efficiency of «Fluvir» preparation in the prevention of frequent respiratory diseases in children and its impact on the indices of the immune system state. 

Patients and methods. A total of 47 children in the age from 3 to 6 years with frequent recurrent acute respiratory infections (FIC) were under observation. All FIC had received Fluvir by two sachets per day for four weeks. The control group consisted of 30 children occasionally ill by ARI. During the course were used the methods of the clinical observations and laboratory tests. 

Results. The study showed a clinical and preventive efficacy of the probiotic preparation «Fluvir». At the heart of preventive action of Fluvir is the activation of production mechanisms of antimicrobial peptides and restore eubiotic state of the mucous membrane of the respiratory tract microflora. 

Conclusions. Reducing of respiratory disease morbidity, alleviation of clinical symptoms of ARVI in patients due to the receiving Fluvira is the basis for its inclusion in the program of prevention and rehabilitation of FIC. 

Key words: frequent respiratory infections, children, stimulation of immunity, probiotics. 

REFERENCES                                                        

1. Albitskiy VYu, Baranov AA. 2006. Chasto boleyuschie deti. Kliniko-sotsialnyie aspektyi, puti ozdorovleniya. Perm: 86.

2. Belkaid Y, Naik S. 2013. Compartmentalized and systemic control of tissue immunity by commensals. Nature immunology. 14: 646—653. http://dx.doi.org/10.1038/ni.2604; PMid:23778791 PMCid:PMC3845005

3. Garcia-Crespo KE et al. 2013. Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection. Antiviral Res. 97: 270—279. http://dx.doi.org/10.1016/j.antiviral.2012.12.022; PMid:23274789 PMCid:PMC3608699

4. Grice E. A. The human microbiome: our second genome / E. A. Grice, J. A. Segre // Annu Rev Genomics Hum Genet. — 2012. — Vol. 13. — P. 151—170.

5. Hsieh MH, Versalovic J. 2008.The human microbiome and probiotics: implications for pediatrics. Curr Probl Pediatr Adolesc Health Care. 38(10): 309—327. http://dx.doi.org/10.1016/j.cppeds.2008.09.001

6. Iakupova RS, Skachkova MA, Choloian SB, Karpova EG. 2012. Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas. Gig Sanit. 3: 33—4. PMid:23088120

7. Ichinohe T et al. 2011. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA. 108: 5354—5359. http://dx.doi.org/10.1073/pnas.1019378108; PMid:21402903 PMCid:PMC3069176

8. Kleerebezem M, Boekhorst J, van Kranenburg R et al. 2003, Feb 18. Complete genome sequence of Lactobacillus plantarum WCFS1. Proc Natl Acad Sci USA. 100(4): 1990—5. http://dx.doi.org/10.1073/pnas.0337704100; PMid:12566566 PMCid:PMC149946

9. Lavelle EC, Murphy C, O'Neill LA, Creagh EM. 2010. The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol. 3: 17—28. http://dx.doi.org/10.1038/mi.2009.124; PMid:19890268 PMCid:PMC3428627

10. Molloy MJ, Bouladoux N, Belkaid Y. 2012. Intestinal microbiota: Shaping local and systemic immune responses. Seminars in Immunology. 24; Issue 1: 58—66. http://dx.doi.org/10.1016/j.smim.2011.11.008; PMid:22178452 PMCid:PMC3292882

11. Petrof EO, Dhaliwal R, Manzanares W et al. 2012. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Critical Care Medicine. 40(12): 3290—302. http://dx.doi.org/10.1097/CCM.0b013e318260cc33; PMid:22975886

12. Salzman NH, Underwood MA, Bevins CL. 2007. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol. 19: 70-83. http://dx.doi.org/10.1016/j.smim.2007.04.002; PMid:17485224

13. Sybesma W, Molenaar D, van I Jcken W, Venema K, Kort R. 2013. Genome instability in Lactobacillus rhamnosus GG. Appl Environ Microbiol. 79(7): 2233—9. http://dx.doi.org/10.1128/AEM.03566-12.